NM_001387283.1:c.5007+9G>C
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001387283.1(SMARCA4):c.5007+9G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000143 in 1,398,202 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: not found (cov: 33) 
 Exomes 𝑓:  0.0000014   (  0   hom.  ) 
Consequence
 SMARCA4
NM_001387283.1 intron
NM_001387283.1 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.262  
Publications
0 publications found 
Genes affected
 SMARCA4  (HGNC:11100):  (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012] 
SMARCA4 Gene-Disease associations (from GenCC):
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9). 
BP6
Variant 19-11060196-G-C is Benign according to our data. Variant chr19-11060196-G-C is described in ClinVar as Likely_benign. ClinVar VariationId is 1616753.Status of the report is criteria_provided_single_submitter, 1 stars. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| SMARCA4 | ENST00000646693.2 | c.5007+9G>C | intron_variant | Intron 35 of 35 | NM_001387283.1 | ENSP00000495368.1 | ||||
| SMARCA4 | ENST00000344626.10 | c.4911+9G>C | intron_variant | Intron 34 of 34 | 1 | NM_003072.5 | ENSP00000343896.4 | |||
| SMARCA4 | ENST00000643549.1 | c.4917+9G>C | intron_variant | Intron 34 of 34 | ENSP00000493975.1 | |||||
| SMARCA4 | ENST00000541122.6 | c.4821+9G>C | intron_variant | Intron 34 of 34 | 5 | ENSP00000445036.2 | ||||
| SMARCA4 | ENST00000643296.1 | c.4821+9G>C | intron_variant | Intron 33 of 33 | ENSP00000496635.1 | |||||
| SMARCA4 | ENST00000644737.1 | c.4821+9G>C | intron_variant | Intron 33 of 33 | ENSP00000495548.1 | |||||
| SMARCA4 | ENST00000589677.5 | c.4818+9G>C | intron_variant | Intron 34 of 34 | 5 | ENSP00000464778.1 | ||||
| SMARCA4 | ENST00000643995.1 | c.4332+9G>C | intron_variant | Intron 31 of 31 | ENSP00000496004.1 | |||||
| SMARCA4 | ENST00000644963.1 | c.3561+9G>C | intron_variant | Intron 27 of 27 | ENSP00000495599.1 | |||||
| SMARCA4 | ENST00000644065.1 | c.3543+9G>C | intron_variant | Intron 26 of 26 | ENSP00000493615.1 | |||||
| SMARCA4 | ENST00000642350.1 | c.3405+9G>C | intron_variant | Intron 26 of 26 | ENSP00000495355.1 | |||||
| SMARCA4 | ENST00000643857.1 | c.3171+9G>C | intron_variant | Intron 24 of 24 | ENSP00000494159.1 | |||||
| SMARCA4 | ENST00000538456.4 | c.975+9G>C | intron_variant | Intron 7 of 7 | 3 | ENSP00000495197.1 | 
Frequencies
GnomAD3 genomes  
GnomAD3 genomes 
Cov.: 
33
GnomAD4 exome  AF:  0.00000143  AC: 2AN: 1398202Hom.:  0  Cov.: 33 AF XY:  0.00000145  AC XY: 1AN XY: 689622 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
2
AN: 
1398202
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
1
AN XY: 
689622
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
31552
American (AMR) 
 AF: 
AC: 
0
AN: 
35694
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
25166
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
35730
South Asian (SAS) 
 AF: 
AC: 
2
AN: 
79162
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
49204
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5226
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
1078558
Other (OTH) 
 AF: 
AC: 
0
AN: 
57910
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.525 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  
GnomAD4 genome 
Cov.: 
33
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2    Benign:1 
Feb 03, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.